Overview

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
To examine the effects of different fixed pramlintide:insulin dose ratios in subjects with type 1 diabetes on postprandial plasma glucose concentrations
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Juvenile Diabetes Research Foundation
Treatments:
Insulin
Insulin, Globin Zinc
Islet Amyloid Polypeptide
Pramlintide